FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / final-tax-opinion-letter.docx
final-tax-opinion-letter.docx · 1037-00007

Parties

HARKNESS LLP
Directors Solstice Biomedical Devices Ltd
Solstice Biomedical Devices Ltd
Solstice Medical Technologies Inc
SMT Inc
United States-Ireland Inc
Global Intangible Low-Taxed Inc
US-Ireland Inc

Dates

April 26, 2024
February 9, 2024
April 10, 2024
December 31, 2023
January 18, 2024
March 1, 2034
January 29, 2024
March 8, 2024
December 31, 2025
January 1, 2026

Amounts

€10,000,000
€347.6
€78.4
$2.1
$189.2
€1.00
$1.09
$174.8
€1,000
$214.5

Obligations

To the extent of any inconsistency between this final opinion and the draft opinion previously circulated, this letter shall control
Under this standard, the results of a controlled transaction must be consistent with the results that would have been realized if uncontrolled taxpayers had engaged in the same transaction under the same circumstances
This standard provides that, in the case of any transfer (or license) of intangible property, the income with respect to such transfer or license shall be commensurate with the income attributable to the intangible
Under Section 952 of the Code, a US shareholder of a CFC must include in gross income its pro rata share of the CFC's "Subpart F income
meets the $500 million average annual gross receipts test must be determined on an aggregated basis, taking into account the gross receipts of all persons treated as a single employer with SMT Inc